Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.